Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.

By Kunn Hadinoto, Ajitha Sundaresan, Wean Sin Cheow. European journal of pharmaceutics and biopharmaceutics, 2013

630 citations recorded by the source corpus.

Subfields: Biomaterials, Molecular Biology, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/8f1fa082ea7cd0a1f1345021aa3499a5455f15fa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. Phatsapong Yingchoncharoen
2. D. Richardson
3. D. Kalinowski

In Molecular Biology

1. Phatsapong Yingchoncharoen
2. Linlin Wang
3. Chen Hu
4. D. Richardson
5. D. Kalinowski
6. L. Shao

In Pharmaceutical Science

1. Phatsapong Yingchoncharoen
2. D. Richardson
3. D. Kalinowski

Citations in the corpus

• Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come (2016, methodology): “ESE can be divided into a single and double emulsification.”
• The antimicrobial activity of nanoparticles: present situation and prospects for the future (2017, background): “The negative effects also require attention to prevent the promotion of MDR, which may result in further hazards to public health and the environment.”